---

---

Cancers Commonly Managed

Lung Cancer • Breast Cancer • Gastrointestinal Cancers • Gynecologic Cancers • Hematologic Malignancies

Treatment strategies are guided by disease stage, tumor biology, and molecular characteristics.

---

---

Frequently Asked Questions

What is precision oncology?

Precision oncology involves tailoring cancer treatment based on molecular and genetic characteristics of the tumor. Biomarker testing helps identify whether targeted therapy or immunotherapy may be effective.

When should a second opinion be considered?

A second opinion is useful at diagnosis, before starting treatment, before major surgery, or when treatment options are unclear. A structured review can refine treatment decisions.

Can cancer treatment be offered safely in older adults?

Yes. Treatment decisions are based on overall fitness rather than age alone. A structured geriatric oncology approach helps optimize safety and outcomes.

Does being younger make cancer treatment easier?

No. Younger patients may have different disease biology and unique concerns such as fertility, long-term side effects, and survivorship planning.

---

Cancer treatment should be guided by disease biology, functional status, and patient-specific goals rather than age-based assumptions.

When Should You See a Medical Oncologist?

---

A medical oncologist plays a central role in diagnosing, staging, and planning treatment for cancer. Early consultation ensures that treatment decisions are structured, evidence-based, and aligned with the latest advances in precision oncology.

• New cancer diagnosis → To understand stage, prognosis, and treatment options
• Conflicting medical opinions → To obtain a structured second opinion
• Consideration of chemotherapy, immunotherapy, or targeted therapy
• Advanced or metastatic cancer → For systemic treatment planning
• Need for molecular or genetic testing → To guide personalized therapy
• Before major surgery or high-risk treatment decisions

Early and informed decision-making can significantly influence both treatment outcomes and long-term quality of life.

Precision Oncology Approach

---

Modern cancer treatment is no longer uniform. Precision oncology focuses on understanding the unique biology of each patient’s cancer to guide individualized treatment decisions.

• Molecular profiling → Identifying actionable mutations such as EGFR, ALK, HER2, and others
• Cancer genetics → Evaluating inherited risk through germline testing when appropriate
• Biomarker-driven therapy → Selecting targeted therapy or immunotherapy based on tumor characteristics
• Structured treatment planning → Integrating pathology, imaging, and molecular data
• Multidisciplinary coordination → Aligning systemic therapy with surgery and radiation

This approach allows treatment to be tailored—not only to the disease, but also to the individual—improving outcomes while minimizing unnecessary toxicity.

How Treatment Decisions Are Made in Modern Oncology

---

Cancer treatment decisions are based on a structured clinical framework that integrates disease stage, tumor biology, patient factors, and available evidence. This ensures that each treatment plan is individualized and clinically justified.

• If the cancer is early-stage and localized
  → Surgery with or without adjuvant therapy is typically considered
• If actionable molecular markers are present
  → Targeted therapy may be preferred over conventional chemotherapy
• If immunotherapy biomarkers (PD-L1, MSI, TMB) are significant
  → Immunotherapy becomes an important component of treatment
• If the patient is elderly or medically frail
  → Treatment intensity is adjusted to balance efficacy and safety
• If multiple treatment strategies are available
  → A structured second opinion helps optimize sequencing and outcomes

This decision-making process reflects the shift from standardized protocols to personalized cancer care based on precision oncology principles.